I.V Papavrine for Labor Induction in Term PROM
Recruiting
Phase 4
Interventional Study
Premature Rupture of Membranes
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 45
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 110 (estimated)
- Sponsor
- Western Galilee Hospital-Nahariya · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective randomized controlled trial aims to evaluate whether intravenous administration of papaverine 12 hours after term PROM reduces the interval from membrane rupture to delivery and improves maternal and neonatal outcomes. Researchers will compare drug papaverine to a placebo
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* • Singleton pregnancy
* Term gestation (37-42 weeks)
* Term PROM prior to active labor
* Duration of PROM \<12 hours at enrollment
* Bishop score \<8
* Cephalic presentation
* Viable fetus with reassuring fetal heart rate
Exclusion Criteria:
* • Multiple gestati…
Contacts